z-logo
open-access-imgOpen Access
FDA Approves First Biosimilar, Zarxio
Author(s) -
Janet Colwell
Publication year - 2015
Publication title -
cancer discovery
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.795
H-Index - 163
eISSN - 2159-8290
pISSN - 2159-8274
DOI - 10.1158/2159-8290.cd-nd2015-002
Subject(s) - biosimilar , drug approval , medicine , neutropenia , cancer drugs , pharmacology , drug , business , toxicity

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

AboutCareersPublisher PartnersContact UsOur institutional solutionsGet Organisational Trial or Quote

Learn

FAQsBlogTerms of UsePrivacy Policy

Download the Zendy App

Get it on
Google Play
Download on the
App Store

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.
HomeZAIABlog